Swiss National Bank Veru Inc. Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$1.16 - $6.41 $19,256 - $106,406	-16,600 Reduced 10.72%	138,300 $160,000
Q4 2022 Feb 08, 2023	BUY	$4.78 - $15.01 $18,642 - $58,539	3,900 Added 2.58%	154,900 $817,000
Q1 2022 May 09, 2022	BUY	$4.55 - $6.41 $45,955 - $64,741	10,100 Added 7.17%	151,000 $729,000
Q3 2021 Nov 08, 2021	BUY	$6.78 - $9.89 $18,306 - $26,703	2,700 Added 1.95%	140,900 $1.2 Million
Q2 2021 Aug 06, 2021	BUY	$7.24 - $11.2 $1 Million - $1.55 Million	138,200 New	138,200 $1.12 Million

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.